Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

Emerald Clinical Trials Rebrands from George Clinical

Clinical Trials: Emerald Clinical Trials is a leading clinical research organization operating worldwide that serves over 100 biotechs, and 6 of the top 10 pharmaceutical companies. Headquartered in Singapore and driven by operational expertise and...

Glenmark Pharmaceuticals Launches Vancomycin Hydrochloride for Injection in the U.S

Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch1 of Vancomycin Hydrochloride for Injection USP, 750 mg/vial, 1.25 g/vial and 1.5 g/vial (Single-dose vial). Glenmark's Vancomycin Hydrochloride for Injection USP, 750 mg/vial, 1.25...

Cognito Therapeutics Presents Spectris™ Data on Brain Structural Maintenance in Alzheimer’s at AD/PD™ 2025

Initiative (ADNI), Spectris patients maintained brain volume (+0.58%) while matched ADNI controls showed a decline (-0.91%), a net difference of +1.49% (p

PeptiGrowth Inc. Launches Novel Synthetic KGF Alternative Peptide (FGFR2b Agonist)

chemically synthesized and animal component-free, enabling xeno-free and chemically defined cell culture media. PG-012, KGF alternative peptide, is a dimeric peptide composed of cyclic peptides designed to bind specifically to FGFR2b. Like KGF,...

Hanmi Pharmaceutical Launches 'Aditams' in Mexico, Expanding into Latin America

active ingredients into a single capsule. Laboratorios Silanes, a leading pharmaceutical company in Mexico founded in 1943, is committed to providing innovative healthcare solutions and driving rapid growth in the industry. It has established...

ELIQUENT Life Sciences Acquires Truliant Consulting, Expanding Pharmacovigilance Platform

support models that grow with your business—ensuring the right expertise, at the right time. About Truliant: Founded in 2021 and headquartered in Baltimore, Maryland, Truliant Consulting is a women-owned business specializing in pharmacovigilance...

Fast Company recognizes Bruin Biometrics as a top 10 innovative medical device maker

and management to health systems in the U.S. and U.K., announced it has been named by Fast Company as one of the World's 10 Most Innovative Companies in the medical device category. Profiled in the publication's March 18 feature, Bruin Biometrics...

Medline to launch a synthetic ligament augmentation implant.

Headquartered in Northfield, Illinois, the company employs more than 43,000 people worldwide and operates in more than 100 countries and territories. For more information please visit www.medline.com.

Pint Pharma secures ANVISA approval for BESREMi® to treat Polycythemia Vera

can progress to secondary myelofibrosis or leukemia. The global incidence of PV is estimated at approximately 2.8 cases per 100,000 people per year. In Brazil, between 2016 and 2020, DataSUS recorded 1,843 cases of Polycythemia Vera, representing...

Secretome Therapeutics' STM-01, a neonatal cardiac progenitor cell therapy for HFpEF, receives FDA Fast Track designation

medicine, announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to STM-01, the company’s neonatal cardiac progenitor cell (nCPC) therapy, for the treatment of Heart Failure with Preserved Ejection Fraction...

Developing innovative production technology for the commercialization of 3D cell products, PHC and Cyfuse collaborate

President: Kyoko Deguchi), and Cyfuse Biomedical K.K. announce the successful development of a new production technology(*1) for the commercialization of the field of regenerative and cell therapy. This achievement is the result of a strategic...

Marking a new era of uncovering the potential of NAD+ with precision science, ChromaDex evolves into Niagen Bioscience

Company’s common stock will begin trading under the new Nasdaq symbol “NAGE” at stock market open today, Wednesday, March 19, 2025. The CUSIP number for the Company's common stock will remain the same. With a legacy spanning over 25 years, this...

Medit introduces SmartX, a new All-on-X solution for digital dentistry

on prosthetic types (e.g., Provisional Bridge, Denture) for an expanded workflow. Medit revolutionized the market in 2018 with its first intraoral scanner, offering high precision and user-friendly options at a significantly lower cost than...

Actinium Pharmaceuticals publishes Actimab-A + CLAG-M trial results for relapsed/refractory AML in Leukemia

treating relapsed refractory AML patients with CLAG-M. Actimab-A + CLAG-M Trial Data Highlights from Publication: 18.4 month median Overall Survival (OS) in patients who received 1 or 2 lines of prior therapy 52% of patients in the Actimab-A...

Applications Are Being Accepted by the Vilcek Foundation from Immigrants Working in Biomedical Science

by the couple's respective careers in biomedical science and art history. Since 2000, the foundation has awarded over $15 million in prizes and grants. The Vilcek Foundation is a private operating foundation, a federally tax-exempt nonprofit...

Key Results from Lutetium (177Lu) rhPSMA-10.1 Injection Phase 1 Clinical Trial Reported by Blue Earth Therapeutics

labelled, PSMA targeted, investigational radioligand therapy. Radiation dosimetry and pharmacokinetic data from the 13 metastatic castrate resistant prostate cancer patients enrolled in the Phase 1 portion of a Phase 1/2 clinical trial...

Fzata secures a clinical trial agreement for FZ002, targeting C. difficile treatment.

Inc. announces the execution of a clinical trial agreement with the National Institutes of Health (NIH) to sponsor a Phase 1 clinical trial of FZ002 for C. difficile treatment. Oral FZ002 is a live yeast genetically modified to express a...

Peer-Reviewed Study in Obesity Pillars Further Substantiates Cardiovascular Safety Profile of CONTRAVE®/MYSIMBA, according to Currax Pharmaceuticals

Currax Pharmaceuticals LLC a specialty pharmaceutical company and manufacturer of the #1 branded oral weight loss medication CONTRAVE® (naltrexone HCl/bupropion HCl), announced the publication of its Cardiovascular Health Outcomes Analysis (HOA)...

Viking Therapeutics and CordenPharma Sign Long-Term Strategic Partnership for Integrated Supply of GLP-1 Peptides, Injectables, and Oral Formulations

CordenPharma provides development and manufacturing services for clinical and commercial demand of Viking Therapeutics' GLP-1 drug candidate VK2735, a Dual GLP-1/GIP Receptor Agonist, across the full supply chain from drug substance to drug product...

Kenox Pharmaceuticals announces a strategic collaboration with Lactiga to advance immunotherapy targeting mucosal areas

potential to transform the lives of individuals with immunodeficiency. About Kenox Pharmaceuticals Inc.: Established in 2018 and based in the greater Princeton area, NJ, Kenox specializes in pharmaceutical aerosol product development, including...